parthenolide has been researched along with Cardiometabolic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barroso, E; Chacón, MR; Garrido-Sánchez, L; Maymó-Masip, E; Palomer, X; Salvadó, L; Serrano-Marco, L; Tinahones, FJ; Vázquez-Carrera, M; Vendrell, J; Wabitsch, M | 1 |
1 trial(s) available for parthenolide and Cardiometabolic Syndrome
Article | Year |
---|---|
TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
Topics: Active Transport, Cell Nucleus; Adipocytes; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cell Nucleus; Cells, Cultured; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Obesity; PPAR delta; PPAR-beta; Sesquiterpenes; Sirtuin 1; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |